BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2531473)

  • 1. [The results of 5 years' use of a method for heparin cryoprecipitation of plasma proteins (selective plasmapheresis) in patients with an immune-complex pathology].
    Margulis EIa; Savchenko VG
    Ter Arkh; 1989; 61(7):65-9. PubMed ID: 2531473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effectiveness of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) in patients with immune complex pathology].
    Margulis EIa; Savchenko VG; Vasil'ev SA; Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1985; 57(7):125-31. PubMed ID: 2931845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) on the level of immune complexes in the blood].
    Savchenko VG; Margulis EIa; Vasiliev SA; Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1985; 57(7):102-7. PubMed ID: 2931844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cryoapheresis on the course of immune complex diseases].
    Margulis EIa; Savchenko VG; Zherdeva LV; Tolkachev AA; Selezneva OM
    Ter Arkh; 1987; 59(6):80-5. PubMed ID: 2957815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].
    Vasil'ev SA; Savchenko VG; Gorodetskiĭ VM; Ermolin GA; Kotelianskiĭ VE
    Ter Arkh; 1984; 56(6):35-9. PubMed ID: 6236575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apheresis of euglobulins, cryoglobulins and the von Willebrand factor in vasculitis].
    Savchenko VG; Iakhnina EI; Margulis EIa; Shklovskii-Kordi NE; Kuznetsov AI
    Ter Arkh; 1987; 59(6):75-9. PubMed ID: 2957814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic plasmapheresis in immune complex diseases].
    Movshev BE; Kalinin NN; Petrova VI
    Ter Arkh; 1994; 66(7):70-3. PubMed ID: 7985137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in rheumatoid arthritis. Selective removal by cryogelation with membrane filtration.
    Krakauer RS; Asanuma Y; Zawicki I; Calabrese L; Malchesky P; Nose Y
    Arch Intern Med; 1982 Feb; 142(2):395-7. PubMed ID: 6977346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis in the treatment of diseases caused by immunologic pathology].
    Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1984; 56(6):19-23. PubMed ID: 6236574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange in immune complex disease.
    Houwert DA; Kater L; Hené RJ; Struyvenberg A
    Proc Eur Dial Transplant Assoc; 1979; 16():520-7. PubMed ID: 162005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative assessment of various programs of plasmapheresis in the combined treatment of patients with rheumatoid arthritis].
    Talybov FIu; Dubrovina NA; Kalinin NN; Petrova VI; Movshev BE
    Klin Med (Mosk); 1992 Feb; 70(2):51-4. PubMed ID: 1507822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis and cold sensitivity of immunoglobulin molecules. II. A study of macroglobulinemia polyclonalis spuria and immune complex disease.
    Waldenström JG
    Acta Med Scand; 1984; 216(5):467-74. PubMed ID: 6240922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of hemosorption and plasmapheresis in the treatment of patients with rheumatoid arthritis, bronchial asthma and hypertension].
    Ananchenko VG; Strizhova NV; Kuznetsov SV; Griaznova NA; Alizade IG
    Klin Med (Mosk); 1991 Aug; 69(8):87-9. PubMed ID: 1838781
    [No Abstract]   [Full Text] [Related]  

  • 14. [Colloid osmotic pressure and the total protein level in assessing the safety of therapeutic plasmapheresis].
    Movshev BE; Semenova GM; Petrova VI; Kalinin NN
    Ter Arkh; 1991; 63(7):30-3. PubMed ID: 1788802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
    Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
    J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complex mediated rheumatic diseases.
    Somer T; Wallace DJ; Fan PT
    Ann Clin Res; 1980 Apr; 12(2):77-86. PubMed ID: 6449901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
    Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
    Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
    Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibronectin and immune complexes in rheumatic diseases].
    Mazepa MA
    Vestn Akad Med Nauk SSSR; 1991; (4):57-61. PubMed ID: 1830993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.